Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Selective Estrogen Receptor Modulators
100%
Estrogen
37%
Human Health
12%
Chemopreventive
12%
Transcription Factor
12%
Clinical Application
12%
Targeted Therapy
12%
Estrogen Receptor
12%
Human Disease
12%
Breast Cancer Mortality
12%
Acquired Resistance
12%
High-risk Women
12%
Therapeutic Efficacy
12%
Drug Class
12%
Estrogen Receptor-positive Breast Cancer
12%
Molecular Study
12%
Estrogen Receptor β
12%
Raloxifene
12%
Estrogen Receptor 1 (ESR1)
12%
Postmenopausal Osteoporosis
12%
Preventive Efficacy
12%
Undesirable Side Effects
12%
Synthetic Molecules
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Selective Estrogen Receptor Modulator
100%
Tamoxifen
50%
Side Effect
37%
Diseases
25%
Estrogen Receptor
12%
Clinical Study
12%
Raloxifene
12%
Chemopreventive Agents
12%
Cancer Incidence
12%
Estrogen Receptor Positive Breast Cancer
12%
Postmenopause Osteoporosis
12%
Transcription Factors
12%
Estrogen Receptor Beta
12%
Estrogen Receptor Alpha
12%